Peripheral retinal cryopexy for subtotal vitreous hemorrhage

Area of Science:

• Ophthalmology
• Diabetic Retinopathy Treatment
• Vitreous Hemorrhage Management

Background:

• Proliferative diabetic retinopathy (PDR) can cause subtotal vitreous hemorrhage, impairing vision.
• Previous treatments like panretinal photocoagulation may not always prevent or resolve vitreous hemorrhage.
• Effective management strategies for vitreous hemorrhage secondary to PDR are crucial.

Purpose of the Study:

• To evaluate the efficacy of peripheral retinal cryopexy in treating subtotal vitreous hemorrhage in patients with PDR.
• To assess the impact of cryopexy on vitreous hemorrhage clearance and visual acuity outcomes.
• To determine the safety and effectiveness of this treatment modality.

Main Methods:

• Peripheral retinal cryopexy was applied to 20 eyes in 15 patients diagnosed with subtotal vitreous hemorrhage due to PDR.
• A follow-up period averaged 16 months post-treatment.
• Visual acuity and hemorrhage status were recorded before and after cryopexy.

Main Results:

• Complete resolution of vitreous hemorrhage occurred in 11 eyes (55%), with partial clearing in six eyes (30%).
• Visual acuity improved in 13 eyes (65%), remained stable in six eyes (30%), and decreased in one eye (5%).
• The treatment demonstrated a positive impact on visual outcomes and hemorrhage resolution.

Conclusions:

• Peripheral retinal cryopexy is an effective treatment for subtotal vitreous hemorrhage in proliferative diabetic retinopathy.
• The procedure offers significant potential for visual acuity improvement and hemorrhage clearance.
• Cryopexy represents a valuable therapeutic option for managing complex cases of diabetic retinopathy-related vision loss.